How Telemedicine and AI are Revolutionizing Chronic Disease Management?
Introduction: The Growing Global Burden of Chronic Diseases
The healthcare sector is changing rapidly because of the growing demand for better ways to manage chronic diseases. As we move toward 2025 and beyond, digital tools are playing an important role in dealing with conditions like diabetes, heart disease, cancer, and respiratory problems. These long-term illnesses are becoming more common, putting a heavy strain on healthcare systems worldwide. To tackle this, new digital solutions are being introduced to help monitor, manage, and treat these conditions. These improvements help patients get better care as well as ease the burden on healthcare resources and make it easier for people to access care.
The rise in chronic diseases makes it clear that digital health technologies are needed to deliver care more effectively. Innovations like remote monitoring, telemedicine, and mobile health apps are changing how patients manage their health, letting them track their condition in real time and stay in touch with doctors without having to visit clinics. These digital and AI tools help healthcare providers respond better to the challenges of chronic diseases by focusing on proactive, patient-centered care. Furthermore, this article explores the main factors driving the market, regional differences, technological progress, and recent trends that are shaping the future of digital health in chronic disease management.
Key Market Drivers:
Aging Global Population and Sedentary Lifestyle Trends
A key reason chronic diseases are on the rise is the world’s aging population. United Nations figures show that by 2050, 16% of people worldwide will be 65 or older, up from 10% in 2025. As people age, they become more likely to develop chronic conditions like diabetes, respiratory problems, and heart disease.
Unhealthy eating, lack of exercise, and higher stress are the main factors driving up rates of conditions such as type 2 diabetes, obesity, and high blood pressure. Diabetes now affects more than 830 million people globally, with cases growing fastest in low- and middle-income countries. Inactivity is also a growing problem—about 1.8 billion adults, or 31% globally, live largely sedentary lives. Because of these trends, there’s a rising need for better ways to manage chronic illnesses, as these health issues are also appearing more often among younger people.
Increasing Healthcare Expenditure and Government Initiatives
As healthcare expenditures continue to rise globally, managing chronic diseases effectively has become a critical priority for both governments and private stakeholders. Chronic disease management, which requires ongoing treatment, monitoring, and lifestyle interventions, often leads to long-term costs, making it a major concern for health systems. As per the Centers for Disease Control and Prevention (CDC), chronic diseases account for nearly 90% of the nation’s healthcare spending in the United States.
In response to this, governments are increasing their investment in healthcare solutions, with a particular focus on preventative care and digital health technologies. These initiatives are designed to reduce the long-term burden of chronic diseases, focusing on prevention, early diagnosis, and cost-effective management through technology.
Expansion of Digital Health Solutions
The digital health revolution has been one of the most transformative developments in healthcare in recent years. Solutions such as remote patient monitoring (RPM), telemedicine platforms, and mobile health apps are increasingly being used to manage chronic diseases. Furthermore, these technologies are significantly improving patient outcomes and reducing the need for in-person visits by enabling healthcare providers to monitor patients in real time. This trend has only accelerated due to the COVID-19 pandemic, which pushed healthcare systems to adopt digital tools rapidly.
Regional Insights:
North America: The Largest Market Share
North America holds the largest share of the global chronic disease management market. The region’s well-established healthcare infrastructure, robust technological adoption, and high healthcare expenditure are key factors driving this dominance. The US, in particular, has made significant strides in integrating digital health solutions, with widespread adoption of telemedicine and health monitoring devices. In 2024, Lirio introduced a second diabetes-focused intervention in collaboration with Cone Health, aims to enhance the management of chronic conditions and improve the patient experience across North Carolina. Furthermore, partnerships between healthcare providers and tech giants like Apple, Google, and Philips are helping to drive innovation in chronic disease management.
Asia-Pacific: The Fastest-Growing Market
Asia-Pacific is expected to experience the fastest growth in the chronic disease management market. Countries like India and China are seeing rising incidences of chronic diseases due to changing lifestyles, urbanization, and increasing life expectancy. In India, about 21% of the elderly population reports having at least one chronic disease, with 17% of elderly individuals in rural areas and 29% in urban areas affected. As healthcare access improves in these regions, there is a growing demand for innovative, cost-effective healthcare solutions. Furthermore, the market for digital health tools is experiencing rapid expansion, driven by the growing prevalence of chronic conditions such as diabetes and hypertension.
.webp)
Technological Trends:
The intersection of healthcare and technology has led to numerous breakthroughs that are transforming chronic disease management. The following technological trends are playing a pivotal role in improving patient care and outcomes:
Integration of AI and Machine Learning in Predictive Care
Artificial Intelligence (AI) and machine learning (ML) are being increasingly integrated into healthcare systems to predict, monitor, and manage chronic conditions. AI algorithms can analyze vast amounts of data from various sources, including wearables, medical records, and patient behavior, to identify patterns that may not be obvious to healthcare providers. This predictive capability allows for early interventions and personalized care plans, improving patient outcomes while reducing the risk of complications. In July 2025, Everlab raised USD10 Million in seed funding to expand its AI-powered preventive healthcare platform. It supported the development of advanced diagnostics, AI agents for personalized care, and integrations with healthcare systems, further advancing the use of AI in healthcare.
Rising Adoption of Wearable Devices and Mobile Health Apps
Wearable health devices, including smartwatches and fitness trackers, have gained significant traction in chronic disease management. These devices track vital health metrics such as heart rate, glucose levels, blood pressure, and oxygen saturation. Combined with mobile health apps, they allow healthcare providers to monitor patients remotely, ensuring timely interventions and personalized care. Aligned with this, in July 2025, Biobeat received FDA clearance for its cuffless blood pressure tracking smartwatch. The device enables noninvasive, remote monitoring of vital signs, advancing wearable health technology for long-term use in various settings. For patients, these devices offer a sense of autonomy, as they can track their health and manage their conditions in real-time.
Cloud-Based Electronic Health Records (EHR) for Chronic Care Management
The use of cloud-based EHR systems is another major advancement in chronic disease management. Oracle unveiled its next-generation EHR at the Oracle Health Summit in October 2024. The AI-powered, cloud-based system simplifies clinical workflows, enhances security, and integrates real-time patient data to improve chronic care management. Moreover, cloud-based EHRs enhance patient outcomes, reduce errors, and increase efficiency by allowing multiple healthcare professionals to access up-to-date medical records. They also enable better tracking of patient history, medications, and test results, ensuring a holistic approach to chronic care management.
Recent News & Developments:
- In June 2025, IQVIA launched AI agents for life sciences and healthcare at GTC Paris, enhancing workflows and accelerating insights. The collaboration with NVIDIA focused on leveraging AI to streamline clinical trials, market assessments, and HCP engagement, marking a significant development in predictive care integration.
- In June 2025, PharmaSens and SiBionics announced a collaboration to develop the niia signature, an all-in-one wearable insulin patch pump. The device integrates insulin delivery with real-time glucose sensing, aiming to simplify diabetes management and reduce the daily burden for users.
- In May 2025, the WHO released new guidelines on balanced national policies for controlled medicines at the Seventy-eighth World Health Assembly. The guidelines aim to improve global access to essential medicines, address supply gaps, and ensure safe, equitable distribution, especially in low- and middle-income countries.
- In 2024, Philips Healthcare launched an AI-powered chronic disease monitoring platform designed to help healthcare providers track and manage conditions like heart disease, diabetes, and COPD. This platform uses machine learning to analyze patient data in real-time, providing insights that can lead to better patient care and early interventions.
- Apple and Fitbit have both expanded their partnerships with health providers to enhance the management of chronic diseases. These collaborations aim to make chronic disease management more accessible, allowing patients to track their conditions and communicate directly with their healthcare providers.
How IMARC Can Help:
IMARC is well-positioned to guide businesses through the rapidly evolving landscape of digital health and chronic disease management. With years of experience in market research and analysis, we offer insights into emerging trends, key players, and investment opportunities in the digital health space.
- Market analysis for digital health trends
- Customized reports on chronic disease management
- Strategic insights into technology adoption in healthcare
- Opportunity identification for pharma and med-tech firms
At IMARC, we help companies make informed decisions by providing data-driven solutions that align with the latest market trends. Whether you are looking to explore new business opportunities, adopt cutting-edge technology, or optimize your chronic disease management strategies, our expert team is here to assist you.
Conclusion:
The digital health solution in chronic disease management is significantly transforming healthcare systems globally. Technological advancements, including AI, wearables, and cloud-based EHRs, are shaping the future of chronic disease management. As we move towards 2025 and beyond, digital health solutions are expected to evolve continuously, unlocking opportunities to enhance patient outcomes, reduce healthcare costs, and improve care quality. This presents significant opportunities for businesses to take the lead in chronic disease management solutions.
To stay ahead in the rapidly evolving digital health market, IMARC Group provides actionable insights and strategic guidance. Contact us to learn how we can help you navigate this dynamic landscape and capitalize on emerging opportunities.
Our Clients
Contact Us
Have a question or need assistance?
Please complete the form with your inquiry or reach out to us at
Phone Number
+91-120-433-0800+1-201-971-6302
+44-753-714-6104
Previous Post
The global multivitamin gummies market consists of chewable dietary supplements that are charged with key vitamins and minerals aimed at maintaining general health and wellness. The gummies present a handy, enjoyable, and easy-to-swallow option to classic pills or tablets, hence are predominantly preferred by children and adults who do not like taking pills.
India's pharmaceutical sector is evolving rapidly, supported by the integration of artificial intelligence (AI) across the value chain. As of 2023, India ranked as the third-largest pharmaceutical producer by volume, accounting for 20% of global generic drug exports.
As Lung Cancer Awareness continues to build global momentum in 2025, Artificial Intelligence (AI) is proving to be a transformative force—not only in clinical diagnostics but also in public education and preventive health efforts. Given that lung cancer remains one of the world’s deadliest cancers, accounting for over 1.8 million deaths each year and a five-year survival rate of just 28.4%, the integration of AI marks a critical turning point.
Observed on May 19, Hepatitis Testing Day 2025 emphasizes the need to "Test. Treat. Eliminate," highlighting the gap in diagnosing hepatitis B and C, which cause over 1.3 million deaths annually. Hepatitis remains a major global health threat, on par with HIV, tuberculosis, and malaria. The growing viral hepatitis market <Viral Hepatitis Market Size | Share, Trends - 2034 > reflects rising demand for better diagnostics, treatments, and integrated care. The WHO warns that without faster testing and treatment, the goal of eliminating hepatitis by 2030 may not be achieved, with disparities in diagnostics, particularly in low- and middle-income countries, hindering progress.
Observed on May 8, World Ovarian Cancer Day 2025 carries the theme “No Woman Left Behind,” reinforcing the urgent need to close the gaps in access, diagnosis, treatment, and care across all regions and socioeconomic groups. Ovarian cancer remains one of the deadliest gynecological cancers, often detected too late due to vague symptoms and limited screening tools. The World Ovarian Cancer Coalition projects a 55% rise in annual cases and nearly 70% more deaths by 2050, with the heaviest burden falling on low- and middle-income countries. Equitable access to early diagnostics, genetic testing, and targeted therapies is critical.
In clinics around the world, a concerning pattern is becoming increasingly evident: a growing number of patients are experiencing wheezing, breathlessness, and persistent coughing. This surge reflects a broader global trend. According to the World Health Organization (WHO), more than 260 million people are currently living with asthma, making it one of the most widespread and persistent chronic respiratory conditions globally.
Observed on April 25, World Malaria Day 2025 carries the theme “Accelerating Equity in Malaria Prevention and Cure,” underscoring the urgent need to reach communities still lacking access to life-saving vaccines and diagnostics. While global malaria death rates have seen modest declines, the disease continues to claim the life of one child every minute, highlighting the critical need for swift, equity-driven action
Sulfamethoxazole is a common synthetic antibacterial that is a member of the sulfonamide class of antibiotics. This substance plays a very significant role in modern medicine due to the amazing capabilities offered by the substance for curing infections and bacterial diseases. Trimethoprim and sulfamethoxazole are frequently used together to create the well-known antibiotic co-trimoxazole, which is well-known for its potency against a variety of bacterial infections. It works by preventing the manufacture of folic acid, which is necessary for the growth of bacteria. Sulfamethoxazole is an essential part of modern antibiotic therapy since it has been used to treat lung infections, urinary tract infections, and other common bacterial illnesses.
Healthcare consumables are necessary medical supplies used for patient treatment, diagnostics, and cleanliness in clinics, hospitals, and home care settings. These consist of supplies such as surgical masks, bandages, gloves, syringes, catheters, and disinfectants. Usually, they are disposable or single use to preserve sterility and stop infections. Healthcare consumables are an essential component of the global healthcare ecosystem and are in high demand due to expanding healthcare needs, an increase in operations, infection control measures, and technological improvements.
Catheters are flexible, tubular medical devices designed to access various body cavities, organs, or blood vessels for diagnostic or therapeutic purposes. They can be broadly classified into types based on their application, including urinary catheters, cardiac catheters, and intravenous (IV) catheters. Catheters are commonly used in diverse healthcare settings for managing chronic conditions, enabling fluid drainage, delivering medications, or facilitating minimally invasive surgeries.
Bioinformatics involves applying computational techniques and tools to study and understand biological systems at the molecular level. It is a field of study that combines mathematics, biology, computer science, and statistics to research genomic data and biological networks. The goal is to interpret information from large biological data sets, such as DNA sequences, protein structures, gene expressions, and other high-throughput experimental data. This field provides various products and services, such as knowledge management tools, bioinformatics platforms, and services.
A non-animal model refers to an experimental system or method used in scientific research or testing that does not involve the use of animals. These models are developed to simulate biological processes, test hypotheses, or study diseases without the need for live animals. The aim is often to reduce the reliance on animal testing, which has ethical implications and raises concerns about animal welfare.
Cell therapy involves the transplantation and manipulation of living cells to replace and repair damaged tissue. Its primary branches include stem cell therapy and non-stem cell therapy. Stem cell therapy utilizes stem cells to repair, replace, or rejuvenate damaged or diseased cells and tissues as they possess the ability to differentiate into various specialized cell types, making them valuable for regenerative medicine. Non-stem cell-based therapies typically involve somatic cells isolated from the human body. These cells are propagated, expanded, selected, and then administered to patients for curative, preventive, or diagnostic purposes. On the other hand, gene therapy seeks to treat diseases by introducing, replacing, or inactivating genes within cells.